Related Image: Gilda's Club NYC Offers Affinity Credit Card to Help New Yorkers Living with Cancer |
(Date:7/2/2009)... by youngsters with the disease , , THUR...e 1 diabetes are more likely to be overweight than...of serious health complications, researchers say. ...ed the weight problems faced by U.S. youngsters wi...ase that usually shows up in childhood or in young...
(Date:7/2/2009)... Tuesday night saw the launch of (RED)ZONES at the...2 kicked off their new tour to a rapturous sold ou...me location areas directly adjacent to the stage w...tickets for the (RED)ZONES are available through a... going to the Global Fund to help fund AIDS progra...
(Date:7/2/2009)...ewswire/ -- "If recent reports of DEA intervention... intense scrutiny from the DEA,s Diversion unit, a...Mr. Jackson,s prescriptions will also be under the...ted with any of Jackson,s prescriptions," said att...ull federal jury acquittal at trial on a 10 count ...
(Date:7/2/2009)...-FirstCall/ -- Cardinal Health today announced tha... directors effective upon the completion of the pl... John B. McCoy who has retired from the board for ...company as a director. , , Downey is the form...armaceuticals, Inc. and past chairman of the Gener...
Breaking Medicine News(10 mins):Health News:Kids With Type 1 Diabetes Often Overweight 2Health News:(RED)ZONES Launch at First U2 360 Degrees Concert in Barcelona 2Health News:(RED)ZONES Launch at First U2 360 Degrees Concert in Barcelona 3Health News:DEA Will Play Hardball in Investigating Michael Jackson's Doctors 2Health News:Cardinal Health Appoints Bruce Downey to Board of Directors; John McCoy Retires From Board After 22 Years 2(Date:6/30/2009)... Accumetrics, Inc. announces that it has reached t... of its landmark clinical trial, GRAVITAS ( G augi... mpact on T hrombosis A nd S afety). The trial... of providing clinicians with actionable informati...grel (Plavix(R)). The multi-center, placebo contr...
(Date:6/30/2009)...ne 30 , - "Study Could Have...,Respect to Infertility Treatment" , New da...is year,s,European Society of Human Reproduction ...in the parameters of the simulation model used, th...(highly-purified human menopausal,gonatropin or H...
(Date:6/29/2009)...atients achieved primary and secondary endpoints ,...- AcelRx Pharmaceuticals, Inc. today announced pos...dy evaluating the safety and efficacy of its ARX-0...ute post-operative pain in patients requiring opio...lacebo, patients receiving ARX-01 Sufentanil NanoT...
(Date:6/28/2009)...ire-FirstCall/ -- Sangamo BioSciences, Inc. (Nasda...lestone has been achieved in its Research and Lice... member of the Roche Group, for the generation of ...utical protein production purposes using Sangamo,s...ase (ZFN) technology. Genentech scientists demonst...
Breaking Medicine Technology:Accumetrics, Inc. Announces GRAVITAS Trial 50 Percent Enrolled 2New Data Supports Significant Economic and Clinical Value of MENOPUR(R) in IVF 2New Data Supports Significant Economic and Clinical Value of MENOPUR(R) in IVF 3New Data Supports Significant Economic and Clinical Value of MENOPUR(R) in IVF 4AcelRx Announces Positive Phase 2 Results from a Study of ARX-01 Sufentanil NanoTabs in Treating Post-Operative Pain 2AcelRx Announces Positive Phase 2 Results from a Study of ARX-01 Sufentanil NanoTabs in Treating Post-Operative Pain 3AcelRx Announces Positive Phase 2 Results from a Study of ARX-01 Sufentanil NanoTabs in Treating Post-Operative Pain 4Sangamo BioSciences Announces Achievement of Key Milestone in Cell Engineering Agreement With Genentech 2Sangamo BioSciences Announces Achievement of Key Milestone in Cell Engineering Agreement With Genentech 3Retirement Community Move in Special 3A 2 Months Rent Free Independent Living 27407 1Retirement Community Move in Special 3A 2 Months Rent Free Independent Living 27407 2Workplace Privacy 26amp 3B Security as a Business Strategic Advantage 27402 1Workplace Privacy 26amp 3B Security as a Business Strategic Advantage 27402 2Cytopia Scientific Presentations on JAK2 Inhibitor Program 3299 1Cytopia Scientific Presentations on JAK2 Inhibitor Program 3299 2The frontiers of nanotechnology 8311 1... Mass.--(BUSINESS WIRE)--Jun 25, 2007 - Elixir,Pha...on of two sets,of preclinical data demonstrating t...or future treatment of a range of metabolic,disord...al,metabolic effects, notably decreasing body weig...ls, and reductions in fatty liver.,The data were p...
...S--(BUSINESS WIRE)--Jun 25, 2007 - CytRx Corporati...ged in the,development and commercialization of hu...bility results from its previously,announced doubl...clinical trial in healthy volunteers with its drug...sults of this trial support,the use of arimoclomol...
Other Medicine Technology:Elixir Pharmaceuticals Presents Preclinical Data Highlighting Its,Ghrelin Antagonist Program at the American Diabetes Association's,Annual Meeting 2Elixir Pharmaceuticals Presents Preclinical Data Highlighting Its,Ghrelin Antagonist Program at the American Diabetes Association's,Annual Meeting 3Elixir Pharmaceuticals Presents Preclinical Data Highlighting Its,Ghrelin Antagonist Program at the American Diabetes Association's,Annual Meeting 4CytRx Announces Clinical Results from Its Rising Multiple Dose,Trial with Arimoclomol for ALS 2CytRx Announces Clinical Results from Its Rising Multiple Dose,Trial with Arimoclomol for ALS 3CytRx Announces Clinical Results from Its Rising Multiple Dose,Trial with Arimoclomol for ALS 4CytRx Announces Clinical Results from Its Rising Multiple Dose,Trial with Arimoclomol for ALS 5The standard of proximal press-fit design. The CLS hip is a straight stem design that is available in 13 sizes in two different neck angles, 135 and 145, to accommodate a wide variety of patient anat
The APR Hip System offers a complete line of stems to precisely match patients' anatomic needs and address surgeon preferences.
The APR Hip System offers a complete line of stems to precisely match patients' anatomic needs and address surgeon preferences.
Simple straight stem design for the low-demand patient.
Medicine Products: